Blood transfusions and thinking skills in sickle cell disease
Part of Blood & lymphatic, Genetic & congenital, Mental health clinical trials.
This study looks at whether regular blood transfusions affect thinking and memory in adults with severe sickle cell disease. If you have sickle cell disease and get monthly transfusions, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have severe sickle cell disease (SS or Sβ0 types)
- You already receive a blood transfusion every month
- You do not have dementia or severe aphasia (trouble speaking or understanding language)
- You can speak and understand French well enough for testing
- You have a computer, tablet, or phone with a screen at least 11 inches and internet access
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood vessel function in the fingers (using a simple test called arterial tonometry) relates to thinking and memory in people with sickle cell disease. It involves a non-invasive measurement and cognitive tasks.
This study looks at how major organs like the brain, kidneys, heart, and liver are affected in adults with sickle cell disease, whether they've had a bone marrow transplant or gene therapy, or are continuing regular treatment. You'll get detailed tests that can help doctors understand the disease better, which may lead to improved care.
This study uses two brain scans—transcranial Doppler (TCD) and magnetic resonance angiography (MRA)—to monitor blood flow and arteries in children with sickle cell anemia. It aims to help guide future treatment and prevent strokes.
This study looks at whether certain genes make people with sickle cell disease more likely to develop an immune reaction to blood transfusions. It aims to help doctors predict transfusion risks and improve care.
This study tests whether giving regular blood transfusions during early pregnancy can help prevent complications for women with sickle cell disease. If you are between 6 and 20 weeks pregnant, you may join to see if this treatment improves outcomes.
This study looks at whether red blood cell exchange (a treatment that replaces some of your blood with donor blood) can help reduce inflammation and blood clotting problems in people with sickle cell disease. If you are already on this treatment, it may help doctors understand how it affects your body.
Hear when a new Drepanocytosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.